OTRK vs. BRTX, MGRX, GBNHF, SSKN, PPBT, RDHL, MBOT, KPRX, NXGL, and COEP
Should you be buying Ontrak stock or one of its competitors? The main competitors of Ontrak include BioRestorative Therapies (BRTX), Mangoceuticals (MGRX), Greenbrook TMS (GBNHF), STRATA Skin Sciences (SSKN), Purple Biotech (PPBT), RedHill Biopharma (RDHL), Microbot Medical (MBOT), Kiora Pharmaceuticals (KPRX), NEXGEL (NXGL), and Coeptis Therapeutics (COEP). These companies are all part of the "medical" sector.
BioRestorative Therapies (NASDAQ:BRTX) and Ontrak (NASDAQ:OTRK) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, media sentiment, dividends, analyst recommendations, community ranking and profitability.
Ontrak received 37 more outperform votes than BioRestorative Therapies when rated by MarketBeat users.
Ontrak has a consensus target price of $4.00, suggesting a potential upside of 1,468.63%. Given BioRestorative Therapies' higher probable upside, analysts clearly believe Ontrak is more favorable than BioRestorative Therapies.
Ontrak has a net margin of -186.35% compared to Ontrak's net margin of -9,873.97%. Ontrak's return on equity of -114.84% beat BioRestorative Therapies' return on equity.
In the previous week, Ontrak had 3 more articles in the media than BioRestorative Therapies. MarketBeat recorded 6 mentions for Ontrak and 3 mentions for BioRestorative Therapies. BioRestorative Therapies' average media sentiment score of 0.54 beat Ontrak's score of 0.00 indicating that Ontrak is being referred to more favorably in the news media.
BioRestorative Therapies has a beta of 62.12, suggesting that its stock price is 6,112% more volatile than the S&P 500. Comparatively, Ontrak has a beta of 2.5, suggesting that its stock price is 150% more volatile than the S&P 500.
BioRestorative Therapies has higher earnings, but lower revenue than Ontrak. BioRestorative Therapies is trading at a lower price-to-earnings ratio than Ontrak, indicating that it is currently the more affordable of the two stocks.
69.4% of BioRestorative Therapies shares are held by institutional investors. Comparatively, 13.0% of Ontrak shares are held by institutional investors. 21.6% of BioRestorative Therapies shares are held by company insiders. Comparatively, 1.2% of Ontrak shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
Ontrak beats BioRestorative Therapies on 9 of the 16 factors compared between the two stocks.
Get Ontrak News Delivered to You Automatically
Sign up to receive the latest news and ratings for OTRK and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OTRK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
